From the Editor

There is a longstanding debate about the role of ambulatory blood pressure monitoring in clinical practice. One view is that ambulatory monitoring should only be obtained infrequently because it is only in marginal situations where the information provided will impact clinical treatment decisions. One such example is a patient with modestly elevated office blood pressure, but no evidence of target organ damage and otherwise low risk for cardiovascular disease. Another position is that ambulatory blood pressure monitoring is able to detect “white coat” hypertension and “masked” hypertension, which are not apparent in the office setting, and that this information may have implications for treatment.
Source: Journal of the American Society of Hypertension - Category: Cardiology Authors: Tags: Editor's Page Source Type: research